Welcome, Sign In
Bausch & Lomb Nears $9B Sale, and More
Description:What’s News: Bausch & Lomb is close to a deal to sell itself to Valeant Pharmaceuticals for about $9 billion. Durable goods rebound in April. Large explosions and gunbattles rock Kabul, Afghanistan. Joanne Po reports. Photo: AP.
The Wall Street Journal